« Return to News | Awards & Advancement

Plasticell wins R&D 100 award

Wednesday, June 29, 2011 12:44 PM

Plasticell, a biotechnology company specializing in high-throughput technologies for directed stem cell differentiation, has won the R&D 100 Award for its CombiCult v2.0 system.

The CombiCult platform is a high-throughput combinatorial screening technology that allows scientists to discover optimal stem cell differentiation protocols in record time, revolutionizing stem cell research and opening new avenues of discovery.

The introduction of CombiCult marked an advancement in stem cell R&D, as it targets a critical bottleneck in any stem cell research program—developing protocols that optimally direct stem cells to develop into a differentiated cell type of choice. The terminally differentiated cells have numerous applications in biomedical research and regenerative medicine.

Innovations in CombiCult 2.0, include a streamlined workflow with specially developed laboratory consumables and automation, and powerful proprietary bioinformatics software that result in marked improvements in speed and reliability compared to the first-generation platform. CombiCult has been deployed internally and by customers on a variety of adult and embryonic stem cells to generate a wide range of tissue types including blood, neuron, bone, cartilage, liver and heart.

The R&D 100Awards, also known as the “Oscars of Innovation,” is now in its 49th year and recognizes the 100 most technologically significant products of the year.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.